Latest news
PolyPid's Double Win: D-PLEX₁₀₀ Gains NDA Acceptance and Priority Review, Ahead of Schedule (NASDAQ: PYPD) - TradingViewTradingView · Fri, 31 Jul 2026 15:28:54 GMTPolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀ - The Manila TimesThe Manila Times · Wed, 29 Jul 2026 12:43:27 GMTPolyPid (Nasdaq: PYPD) gets FDA Priority Review and $15M milestone - Stock TitanStock Titan · Wed, 29 Jul 2026 12:35:40 GMTFDA Acceptance Triggers $15M Payment to PolyPid Under Partnership - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT